PDE5 inhibition and Alzheimer's disease risk: a mendelian randomisation study
Alcalde-Herraiz, M.; Woolf, B.; Xie, J.; Anderson, E.; Gill, D.; Tzoulaki, I.; Winchester, L. M.; Yarmolinksy, J.; Prieto-Alhambra, D.; Newby, D.
Show abstract
INTRODUCTIONWhile preclinical studies suggest that Phosphodiesterase 5 (PDE5) inhibition may reduce cognitive impairment, findings from observational studies on whether PDE5 inhibitors reduce Alzheimers disease (AD) risk have been inconsistent. METHODSA two-sample cis-Mendelian Randomisation (MR) analysis was conducted to estimate the causal effect of PDE5 inhibition on AD risk. The analysis was performed across four different genome-wide association studies (GWAS) of AD to enhance evidence reliability through triangulation. Additionally, a sex-stratified MR analysis using data from UK Biobank was performed to assess potential sex-specific effects. RESULTSNo evidence of a causal association between PDE5 inhibition and AD risk was found in the main analyses or sex-stratified analysis. DISCUSSIONMR findings suggest that PDE5 inhibitors are unlikely to decrease the risk of AD. Further research is needed to thoroughly understand the impact of PDE5 inhibitors on the risk of Alzheimers disease.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Manifestations of genetic risk for Alzheimer's Disease in the blood: a cross-sectional multi-omic analysis in healthy adults aged 18-90+ 96%
- Little genomic support for cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers 95%
- Co-localized SNPs Affecting the Expression of Taste Perception Genes are linked to Alzheimer's Disease 95%
Similar papers in this journal
- The ratio of plasma pTau181 and pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosis 92%
- Adherence to Life’s Essential 8 is associated with delayed white matter aging 90%
- Prediction of brain age using structural magnetic resonance imaging: A comparison of clinical validity of publicly available software packages 90%
Similar papers in this journal
- Variation in VKORC1 is associated with vascular dementia 95%
- Frequency of Variants in Mendelian Alzheimer’s Disease Genes within the Alzheimer’s Disease Sequencing Project (ADSP) 94%
- Brain and Blood Transcriptome-Wide Association Studies Identify Five Novel Genes Associated with Alzheimer’s Disease 94%